tetano
Editor, Senior Moderator
Paediatr Child Health. 2018 Dec;23(8):565-566. doi: 10.1093/pch/pxy150. Epub 2018 Nov 19.
[h=1]Vaccine recommendations for children and youth for the 2018/2019 influenza season.[/h] [Article in English, French]
Moore DL[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Canadian Paediatric Society continues to encourage annual influenza vaccination for all children and youth ≥6 months of age. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2018/2019 influenza season are not substantially changed from those of last season. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised.
[h=4]KEYWORDS:[/h] Children; Inactivated influenza vaccine; Influenza vaccine; LAIV; NACI
PMID: 31043846 PMCID: PMC6241945 [Available on 2019-12-01] DOI: 10.1093/pch/pxy150
[h=1]Vaccine recommendations for children and youth for the 2018/2019 influenza season.[/h] [Article in English, French]
Moore DL[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Canadian Paediatric Society continues to encourage annual influenza vaccination for all children and youth ≥6 months of age. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2018/2019 influenza season are not substantially changed from those of last season. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised.
[h=4]KEYWORDS:[/h] Children; Inactivated influenza vaccine; Influenza vaccine; LAIV; NACI
PMID: 31043846 PMCID: PMC6241945 [Available on 2019-12-01] DOI: 10.1093/pch/pxy150